Tritylolmesartan Medoxomil
Tritylolmesartan Medoxomil (CAS: 144690-92-6) is a protected pharmaceutical intermediate used in the synthesis of olmesartan medoxomil. Its structure contains a trityl-substituted tetrazole and medoxomil ester, making this advanced intermediate relevant to pharmaceutical process chemistry and analytical work associated with the olmesartan medoxomil route. Supplied as a solid, it is also offered as a research or reference-standard material rather than a finished medicine. Handling should follow the lot-specific certificate of analysis and safety data sheet. It is not intended for human or veterinary use.
• Serves as an advanced protected intermediate in the synthesis of olmesartan medoxomil, carrying the trityl-substituted tetrazole structure in the synthetic route.
• Supports pharmaceutical process-development work, including route evaluation and analytical monitoring of olmesartan medoxomil preparation.
• Pharmaceutical reference-standard and research offerings are used in analytical method development, method validation, identity testing, and quality-control workflows.
• Laboratory applications also include impurity profiling and identification or quantification of pharmaceutical compounds; the material is for research use and not for human use.
Product Name: Tritylolmesartan Medoxomil
For global customers, we provide complete technical documentation to support product evaluation, regulatory compliance and safe handling during transportation and application.